Literature DB >> 27379614

Affective lability and difficulties with regulation are differentially associated with amygdala and prefrontal response in women with Borderline Personality Disorder.

Jennifer A Silvers1, Alexa D Hubbard2, Emily Biggs3, Jocelyn Shu4, Eric Fertuck5, Sadia Chaudhury3, Michael F Grunebaum3, Jochen Weber4, Hedy Kober6, Megan Chesin3, Beth S Brodsky3, Harold Koenigsberg7, Kevin N Ochsner4, Barbara Stanley8.   

Abstract

The present neuroimaging study investigated two aspects of difficulties with emotion associated with Borderline Personality Disorder (BPD): affective lability and difficulty regulating emotion. While these two characteristics have been previously linked to BPD symptomology, it remains unknown whether individual differences in affective lability and emotion regulation difficulties are subserved by distinct neural substrates within a BPD sample. To address this issue, sixty women diagnosed with BPD were scanned while completing a task that assessed baseline emotional reactivity as well as top-down emotion regulation. More affective instability, as measured by the Affective Lability Scale (ALS), positively correlated with greater amygdala responses on trials assessing emotional reactivity. Greater difficulties with regulating emotion, as measured by the Difficulties with Emotion Regulation Scale (DERS), was negatively correlated with left Inferior Frontal Gyrus (IFG) recruitment on trials assessing regulatory ability. These findings suggest that, within a sample of individuals with BPD, greater bottom-up amygdala activity is associated with heightened affective lability. By contrast, difficulties with emotion regulation are related to reduced IFG recruitment during emotion regulation. These results point to distinct neural mechanisms for different aspects of BPD symptomology.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Amygdala; Borderline Personality Disorder; Emotion regulation; Prefrontal cortex; fMRI

Mesh:

Year:  2016        PMID: 27379614      PMCID: PMC4992645          DOI: 10.1016/j.pscychresns.2016.06.009

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  78 in total

1.  FACTOR ANALYSIS OF SOME PSYCHOMETRIC MEASURES OF IMPULSIVENESS AND ANXIETY.

Authors:  E S BARRATT
Journal:  Psychol Rep       Date:  1965-04

Review 2.  Neuroimaging studies of working memory: a meta-analysis.

Authors:  Tor D Wager; Edward E Smith
Journal:  Cogn Affect Behav Neurosci       Date:  2003-12       Impact factor: 3.282

Review 3.  How is affective instability defined and measured? A systematic review.

Authors:  S Marwaha; Z He; M Broome; S P Singh; J Scott; J Eyden; D Wolke
Journal:  Psychol Med       Date:  2013-09-27       Impact factor: 7.723

Review 4.  Neurobiological and behavioural studies of affective instability in clinical populations: a systematic review.

Authors:  Matthew R Broome; Zhimin He; Mashal Iftikhar; Julie Eyden; Steven Marwaha
Journal:  Neurosci Biobehav Rev       Date:  2015-02-04       Impact factor: 8.989

5.  Preoccupied attachment and emotional dysregulation: specific aspects of borderline personality disorder or general dimensions of personality pathology?

Authors:  Lori N Scott; Yookyung Kim; Kimberly A Nolf; Michael N Hallquist; Aidan G C Wright; Stephanie D Stepp; Jennifer Q Morse; Paul A Pilkonis
Journal:  J Pers Disord       Date:  2013-04-15

6.  Gender patterns in borderline personality disorder.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2011-05

Review 7.  Impulsivity in borderline personality disorder: a matter of disturbed impulse control or a facet of emotional dysregulation?

Authors:  Alexandra Sebastian; Gitta Jacob; Klaus Lieb; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2013-02       Impact factor: 5.285

8.  Neural correlates of emotion processing in borderline personality disorder.

Authors:  Harold W Koenigsberg; Larry J Siever; Hedok Lee; Scott Pizzarello; Antonia S New; Marianne Goodman; Hu Cheng; Janine Flory; Isak Prohovnik
Journal:  Psychiatry Res       Date:  2009-04-24       Impact factor: 3.222

9.  Refining the borderline personality disorder phenotype through finite mixture modeling: implications for classification.

Authors:  Mark F Lenzenweger; John F Clarkin; Frank E Yeomans; Otto F Kernberg; Kenneth N Levy
Journal:  J Pers Disord       Date:  2008-08

Review 10.  Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders.

Authors:  Stefan G Hofmann
Journal:  Clin Psychol Rev       Date:  2007-05-03
View more
  5 in total

1.  PTSD symptoms and alcohol-related problems among veterans: Temporal associations and vulnerability.

Authors:  Jeffrey S Simons; Raluca M Simons; Jessica A Keith; Kevin J Grimm; Scott F Stoltenberg; Carol O'Brien; Kate Andal
Journal:  J Abnorm Psychol       Date:  2018-10-04

2.  Brain metabolism changes in women with BPD undergoing olanzapine treatment.

Authors:  Jazmin Camchong; Kathryn R Cullen; Kelvin O Lim; S Charles Schulz
Journal:  Psychiatry Res Neuroimaging       Date:  2018-07-27       Impact factor: 2.376

Review 3.  Borderline Personality Disorder (BPD): In the Midst of Vulnerability, Chaos, and Awe.

Authors:  Filiz Kulacaoglu; Samet Kose
Journal:  Brain Sci       Date:  2018-11-18

4.  Functional Connectivity Density, Local Brain Spontaneous Activity, and Their Coupling Strengths in Patients With Borderline Personality Disorder.

Authors:  Xiaoxia Lei; Yunjie Liao; Mingtian Zhong; Wanrong Peng; Qian Liu; Shuqiao Yao; Xiongzhao Zhu; Changlian Tan; Jinyao Yi
Journal:  Front Psychiatry       Date:  2018-07-27       Impact factor: 4.157

5.  The nature of the self: Neural analyses and heritability estimates of self-evaluations in middle childhood.

Authors:  Lina van Drunen; Simone Dobbelaar; Renske van der Cruijsen; Mara van der Meulen; Michelle Achterberg; Lara M Wierenga; Eveline A Crone
Journal:  Hum Brain Mapp       Date:  2021-09-03       Impact factor: 5.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.